Оценка эффективности инактивации вируса SARS-CoV-2 на ускорителе ИЛУ-10
Святченко В. А., Баяндин Р. Б., Брязгин А. А., Золин В. В., Гаврилова Е. В., Агафонов А. П., Максютов Р. А. 2020. Оценка эффективности инактивации вируса SARS-CoV-2 на ускорителе ИЛУ-10. COVID19-PREPRINTS.MICROBE.RU. https://doi.org/10.21055/preprints-3111731
1. Guo, Y.R., Cao, Q.D., Hong, Z.S., Tan, Y.Y., Chen, S.D., Jin, H.J., Tan, K.S.,Wang, D.Y., Yan, Y., 2020. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research 7 (1), 1–10.
2. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report –64[EB/OL].[2020-03-24]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200324-sitrep-64-covid-19.pdf?sfvrsn=703b2c40_2.
3. Novel, C.P.E.R.E., 2020. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi 41 (2), 145.; Perlman, 2020;
4. European Centre for Disease Prevention and Control (ECDC), 2020. Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Increased Transmission Beyond China—Fourth Update (PDF, 14th February);
5. World Health Organization (WHO), 2020a. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. (11 March)
6. Брязгин А А, Куксанов Н К, Салимов Р А "Ускорители электронов для промышленного применения, разработанные в ИЯФ им. Г.И. Будкера СО РАН" УФН 188 672–685 (2018)
7. M. Niks, M. Otto M. Towards an optimized MTT assay // J. Immunol. Meth. 1990. Vol. 130, № 1. P. 149-151.